Olena Vlasyuk serves as the Medical Director at Debiopharm, where she leverages her extensive 20 years of experience in the clinical trial industry to drive innovative solutions in clinical development. In her current role, Olena is a permanent member of the clinical development team, actively...
Olena Vlasyuk serves as the Medical Director at Debiopharm, where she leverages her extensive 20 years of experience in the clinical trial industry to drive innovative solutions in clinical development. In her current role, Olena is a permanent member of the clinical development team, actively participating in core and study teams to ensure the successful execution of clinical studies. Her collaborative approach involves working closely with various functions, including Medical Affairs, Program Management, and Business Development, to align strategic goals and enhance project outcomes.
Olena leads the Clinical Development sub-team, providing critical medical expertise that shapes the strategic direction of projects. Her deep understanding of ICH-GCP guidelines and quality assurance processes ensures that all clinical trials adhere to the highest standards of compliance and ethics. She is adept at navigating complex therapeutic areas, drawing on her comprehensive knowledge to guide the development of robust clinical protocols and project documentation.
Key projects under her leadership have focused on advancing novel therapies through rigorous clinical trials, with an emphasis on operational excellence and stakeholder engagement. Olena’s skills in operations management and project management are instrumental in optimizing trial timelines and resource allocation, ultimately driving successful product development. Additionally, her commitment to staff training and management fosters a culture of continuous improvement within her team, empowering colleagues to excel in their roles. With a proven track record in both global and mid-size pharmaceutical environments, Olena Vlasyuk is a pivotal force in advancing Debiopharm’s mission to deliver innovative healthcare solutions.
